1 |
梁振宇,王凤燕,陈子正,等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学,2023,26(11):1287-1298.
|
2 |
MACLEOD M, PAPI A, CONTOLI M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact [J]. Respirology, 2021, 26(6): 532-551.
|
3 |
慢性阻塞性肺疾病急性加重诊治专家组. 慢性阻塞性肺疾病急性加重诊治中国专家共识(2023年修订版)[J]. 国际呼吸杂志,2023,43(2):132-149.
|
4 |
HOGEA S P, TUDORACHE E, FILDAN A P, et al. Risk factors of chronic obstructive pulmonary disease exacerbations [J]. Clin Respir J, 2020, 14(3): 183-197.
|
5 |
林铃,陈平. 慢性阻塞性肺疾病急性加重风险预测的研究进展[J]. 中国医师杂志,2022,24(7): 981-985.
|
6 |
中国老年医学学会呼吸病学分会慢性阻塞性肺疾病学组. 中国老年慢性阻塞性肺疾病临床诊治实践指南[J]. 中华结核和呼吸杂志,2020,43(2):100-119.
|
7 |
PAREKH T M, HELGESON E S, CONNETT J, et al. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial [J]. Ann Am Thorac Soc, 2022, 19(10): 1642-1649.
|
8 |
JO Y S, RHEE C K, KIM K J, et al. Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease [J]. Ther Adv Respir Dis, 2020, 14(1): 1753-1758.
|
9 |
王明航,蔡坤坤,施丁莉,等. 基于回归分析法建立慢性阻塞性肺疾病急性加重风险预测模型与验证[J]. 中华危重病急救医学,2021,33(1):64-68.
|
10 |
PENG J, CHEN C, ZHOU M, et al. A Machine-learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators [J]. Sci Rep, 2020, 10(1): 3118-3125.
|
11 |
WANG Q, PEI G, CHEN L, et al. Factors affecting the length of stay and hospital readmission rates after an acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis [J]. Ann Transl Med, 2022, 10(4): 175-183.
|
12 |
YANG L, LI M, SHU J, et al. A Risk Prediction Model for Prolonged Length of Stay in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Study of 225 Patients in a Single Center in Kunming, China [J]. Med Sci Monit, 2022, 28(2): e934392.
|
13 |
YILMAZ C, ÖZKAN S, ERER O F. Risk assessment and rate of readmission within 30 days of discharge after hospitalization for acute exacerbation of chronic obstructive pulmonary disease [J]. Tuberk Toraks, 2021, 69(3): 328-337.
|
14 |
GU Y, YE X, LIU Y, et al. A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Respir Res, 2021, 22(1): 176-183.
|
15 |
WANG J, DING Y M. Prevalence and risk factors of pulmonary embolism in acute exacerbation of chronic obstructive pulmonary disease and its impact on outcomes: a systematic review and meta-analysis [J]. Eur Rev Med Pharmacol Sci, 2021, 25(6): 2604-2616.
|
16 |
JUNG Y J, KIM E J, HEO J Y, et al. Short-Term Air Pollution Exposure and Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea: A National Time-Stratified Case-Crossover Study [J]. Int J Environ Res Public Health, 2022, 19(5): 2823-2830.
|
17 |
ZHOU C, YI Q, GE H, et al. Validation of Risk Assessment Models Predicting Venous Thromboembolism in Inpatients with Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Multicenter Cohort Study in China [J]. Thromb Haemost, 2022, 122(7): 1177-1185.
|
18 |
DONG H, HAO Y, LI D, et al. Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study [J]. Int J Chron Obstruct Pulmon Dis, 2020, 15(9): 2249-2256.
|
19 |
ADIBI A, SIN DD, SAFARI A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study [J]. Lancet Respir Med, 2020, 8(10): 1013-1021.
|
20 |
ZHANG R, LU H, CHANG Y, et al. Prediction of 30-day risk of acute exacerbation of readmission in elderly patients with COPD based on support vector machine model [J]. BMC Pulm Med, 2022,22(1):292.
|
21 |
WANG Z, LOCANTORE N, HALDAR K, et al. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis [J]. Am J Respir Crit Care Med, 2021, 203(12): 1488-1502.
|
22 |
HUEBNER S T, HENNY S, GIEZENDANNER S, et al. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers [J]. Respiration, 2022, 101(5): 441-454.
|
23 |
JACOBSEN P A, KRAGHOLM K H, TORP-PEDERSEN C, et al. Employment Status, Readmission and Mortality After Acute Exacerbation of COPD. Janssen DJA, Spruit MA, Weinreich UM[J]. Int J Chron Obstruct Pulmon Dis, 2021,16:2257-2265.
|